IL17A and autoimmune disease: We envisioned that a TPD strategy exploiting the lysosome-targeting functions of SR-A may lower the IL-17A levels in certain autoimmune diseases, such as psoriasis with symptomatic skin lesions where the macrophages infiltrate22, and ultimately alleviate inflammation.